Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-038248 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
27,600
Total Value
$222,749.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 9,200 | $3.79 | $34,866.16 | 154,555 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 21, 2026 | Sale | 9,200 | $20.42 | $187,883.32 | 145,355 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | May 21, 2026 | Exercise/Conversion | 9,200 | $0.00 | $0.00 | 70,584 | Direct | โ | View Details |